Jomy George

Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression

Cristan Farmer, Jessica R. Gilbert, Ruin Moaddel et al. · Neuropsychopharmacology · 2020 · 82 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases

Ramya Ramaswami, Kathryn Lurain, Mark N. Polizzotto et al. · Blood Advances · 2021 · 75 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma

Kathryn Lurain, Ramya Ramaswami, Ralph Mangusan et al. · Journal for ImmunoTherapy of Cancer · 2021 · 67 citations · Full text

Life Sciences, Oncology, Pharmacology +17

A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression

Lawrence T. Park, Bashkim Kadriu, Todd D. Gould et al. · The International Journal of Neuropsychopharmacology · 2020 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine

Kristina M. Brooks, Jomy George, Alice K. Pau et al. · Clinical Infectious Diseases · 2018 · 59 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15